• ISSN 1674-8301
  • CN 32-1810/R
Turn off MathJax
Article Contents
Kai Chang, Wanlin Na, Chenxia Liu, Hongxuan Xu, Yuan Liu, Yanyan Wang, Zhongyong Jiang. Peripheral CD4+CD8+ double positive T cells: a potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220094
Citation: Kai Chang, Wanlin Na, Chenxia Liu, Hongxuan Xu, Yuan Liu, Yanyan Wang, Zhongyong Jiang. Peripheral CD4+CD8+ double positive T cells: a potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220094

Peripheral CD4+CD8+ double positive T cells: a potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus

doi: 10.7555/JBR.36.20220094
More Information
  • Corresponding author: Yanyan Wang and Zhongyong Jiang, Division of Cellular and Molecular Diagnostics, Department of Medical Laboratory, The General Hospital of Western Theater Command, 270 Rong Du Avenue, Jinniu District, Chengdu, Sichuan 610083, China. E-mail: wangyanyanmail@126.com and jiangzhongyongmail@126.com
  • Received: 2022-04-27
  • Revised: 2022-07-31
  • Accepted: 2022-08-04
  • Published: 2022-09-28
  • Lupus nephritis (LN) has a high incidence in systemic lupus erythematosus (SLE) patients, but there is a lack of sensitive predictive markers and mechanisms. The purpose of the study was to reveal the association between the CD4+CD8+ double positive T (DPT) lymphocytes and LN. The study included the patients with SLE with no renal impairment (SLE-NRI), LN, nephritic syndrome (NS), or nephritis. Peripheral blood lymphocyte subsets were analyzed by flow cytometry. Biochemical measurements were performed for peripheral blood in accordance with the recommendations proposed by the National Center for Clinical Laboratories. The proportions of DPT cells in LN group were significantly higher than that in SLE-NRI group (t=4.012, P<0.001), NS group (t=3.240, P=0.001), and nephritis group (t=2.57, P=0.011). In LN group, the risk of renal impairment increased significantly in a DPT cells proportion dependent manner. In cases of high proportion of DPT cells, the risk of LN was 5.136 times higher than when the proportion of DPT cells was within the normal range. These findings indicated that the proportion of DPT cells could be a potential marker to evaluate LN susceptibility, and the interference of NS and nephritis could be effectively excluded when assessing the risk of renal impairment during SLE with DPT cells proportion.

     

  • CLC number: R593.242, Document code: A
    The authors reported no conflict of interests.
  • loading
  • [1]
    Yu F, Haas M, Glassock R, et al. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes[J]. Nat Rev Nephrol, 2017, 13(8): 483–495. doi: 10.1038/nrneph.2017.85
    [2]
    Delarche A, Lumbroso C, Fournier A, et al. Incidence and outcome of lupus nephritis in French Polynesia[J]. Clin Nephrol, 2018, 89: 41–49. doi: 10.5414/CN109194
    [3]
    Feng X, Pan W, Liu L, et al. Prognosis for hospitalized patients with systemic lupus erythematosus in China: 5-year update of the Jiangsu cohort[J]. PLoS One, 2016, 11(12): e0168619. doi: 10.1371/journal.pone.0168619
    [4]
    Rahemtullah A, Harris NL, Dorn ME, et al. Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma[J]. Leuk Lymphoma, 2008, 49(10): 1870–1878. doi: 10.1080/10428190802308728
    [5]
    Jiang Z, Liu X, Chang K, et al. Allyl isothiocyanate inhibits the proliferation of renal carcinoma cell line GRC-1 by inducing an imbalance between Bcl2 and Bax[J]. Med Sci Monit, 2016, 22: 4283–4288. doi: 10.12659/MSM.897315
    [6]
    Chang K, Jiang Z, Liu C, et al. The effects of CYP2C19 genotype on the susceptibility for nephrosis in cardio-cerebral vascular disease treated by anticoagulation[J]. Medicine, 2016, 95(38): e4954. doi: 10.1097/MD.0000000000004954
    [7]
    Liu S, Gong Y, Ren H, et al. The prevalence, subtypes and associated factors of hyperuricemia in lupus nephritis patients at chronic kidney disease stages 1–3[J]. Oncotarget, 2017, 8(34): 57099–57108. doi: 10.18632/oncotarget.19051
    [8]
    Ameh OI, Kengne AP, Jayne D, et al. Standard of treatment and outcomes of adults with lupus nephritis in Africa: a systematic review[J]. Lupus, 2016, 25(11): 1269–1277. doi: 10.1177/0961203316640915
    [9]
    Pahar B, Lackner AA, Veazey RS. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines[J]. Eur J Immunol, 2006, 36(3): 583–592. doi: 10.1002/eji.200535520
    [10]
    Parel Y, Chizzolini C. CD4+ CD8+ double positive (DP) T cells in health and disease[J]. Autoimmun Rev, 2004, 3(3): 215–220. doi: 10.1016/j.autrev.2003.09.001
    [11]
    Dashtsoodol N, Shigeura T, Aihara M, et al. Alternative pathway for the development of Vα14+ NKT cells directly from CD4-CD8- thymocytes that bypasses the CD4+CD8+ stage[J]. Nat Immunol, 2017, 18(3): 274–282. doi: 10.1038/ni.3668
    [12]
    Schäfer S, Zernecke A. CD8+ T cells in atherosclerosis[J]. Cells, 2020, 10(1): 37. doi: 10.3390/cells10010037
    [13]
    Abd El-Kader SM, Al-Shreef FM. Inflammatory cytokines and immune system modulation by aerobic versus resisted exercise training for elderly[J]. Afr Health Sci, 2018, 18(1): 120–131. doi: 10.4314/ahs.v18i1.16
    [14]
    Wu Z, Zheng Y, Sheng J, et al. CD3+CD4-CD8- (double-negative) T cells in inflammation, immune disorders and cancer[J]. Front Immunol, 2022, 13: 816005. doi: 10.3389/fimmu.2022.816005
    [15]
    Glatzová D, Cebecauer M. Dual role of CD4 in peripheral T lymphocytes[J]. Front Immunol, 2019, 10: 618. doi: 10.3389/fimmu.2019.00618
    [16]
    Pérez-Antón E, Egui A, Thomas MC, et al. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients[J]. PLoS Negl Trop Dis, 2018, 12(5): e0006480. doi: 10.1371/journal.pntd.0006480
    [17]
    Wu Y, Cai B, Feng W, et al. Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus[J]. Indian J Med Res, 2014, 140(4): 513–519.
    [18]
    Frahm MA, Picking RA, Kuruc JD, et al. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection[J]. J Immunol, 2012, 188(9): 4289–4296. doi: 10.4049/jimmunol.1103701
    [19]
    Ahn SS, Jung SM, Yoo J, et al. Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus[J]. Rheumatol Int, 2019, 39(11): 1937–1944. doi: 10.1007/s00296-019-04445-y
    [20]
    Wang X, Xia Y. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies[J]. Front Immunol, 2019, 10: 1667. doi: 10.3389/fimmu.2019.01667
    [21]
    Rekvig OP. Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks[J]. Clin Exp Immunol, 2015, 179(1): 5–10.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(4)

    Article Metrics

    Article views (29) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return